Indegene reported a 17.1% year-over-year increase in revenue for Q2 FY26, reaching INR8,042 million. The company’s Tectonic platform saw revenue rise to $2 million in H1, driven by four customers. Indegene completed the acquisitions of BioPharm and WARN & CO, expecting growth acceleration over the next 6-8 quarters. The company is investing heavily in GenAI and digital initiatives.
Financial Highlights
Indegene reported revenue of INR8,042 million for Q2 FY26, a 17.1% year-over-year increase and a 5.7% sequential increase. In dollar terms, the growth was 12.4% year-on-year and 3.6% sequentially. Adjusted EBITDA margin for the quarter was 18.2%. PBT grew by 7.3% year-on-year to INR1,331 million, and PAT increased by 11.4% year-on-year to INR1,021 million.
Segment Performance
The Enterprise segment, comprising Enterprise Commercial and Enterprise Medical Solutions, grew by 8.1% quarter-on-quarter and contributed 88.5% of the company’s revenue. The Brand Activation segment saw a decrease of 15.8%.
Tectonic Platform Update
Indegene’s Tectonic platform generated approximately $2 million in revenue during the first half of the year, with participation from four customers, up from two in the previous quarter. The company is optimistic about the pipeline for Tectonic and anticipates further growth.
Strategic Acquisitions
Indegene completed the acquisitions of BioPharm and WARN & CO in October 2025. The company anticipates these investments will accelerate growth over the next 6 to 8 quarters, though with an expected EBITDA margin compression of around 1.5% in the near term. BioPharm is a U.S.-based omnichannel marketing company, while WARN & CO is a U.K.-based consulting firm.
Business Outlook
The company highlighted that the industry is seeing clients actively building on digital and centralization themes, driven by top-down pressures and the potential of AI. Indegene is strengthening its go-to-market engine through increased business development teams, and added consulting, data, and technology capabilities in the U.S. and Europe.
Source: BSE
